February 11, 2021

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing

DECEMBER 2020 Ling Cui, Pamela R. Schroeder and Paul A. Sack Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing Simplified systems were initially developed using this construct to help adjust insulin infusions, but more complex software has since been developed to account for a variety of clinical inpatient scenarios. FDA-approved inpatient electronic glycemic management systems include Glucommander (Glytec), EndoTool …

Glycemia in Early COVID-19 Hospitalization Linked to Mortality

FEBRUARY 2021 Dawn Antoline-Wang Glycemia in Early COVID-19 Hospitalization Linked to Mortality Improved glycemia within the first two or three days of hospitalization is a better predictor of outcomes in COVID-19 patients than glycemia at the time of non-intensive-care-unit (ICU) hospital admission, according to new findings. Glycemia soon after direct ICU admission was not predictive of outcomes in these patients, Dr. …

February 9, 2021

Pandemic Highlights Critical Role of Technology-Driven Glycemic Management as Glytec Propels Customer Base Past 300 Healthcare Facilities

Pandemic Highlights Critical Role of Technology-Driven Glycemic Management as Glytec Propels Customer Base Past 300 Healthcare Facilities Nationally-Recognized Research and the Imperative for Health Systems to Free Beds and Improve Outcomes More Quickly Fuel Insulin Dosing Technology Company’s Growth WALTHAM, MASS. (February 9, 2021) –Glytec, the only provider of insulin management software across the continuum of care, today announced that health …

January 28, 2021

Experts Explain Why People With Diabetes Should Get the COVID-19 Vaccine

JANUARY 2021 Kayla Hui, MPH Experts Explain Why People With Diabetes Should Get the COVID-19 Vaccine Trying to stay healthy after contracting COVID-19 is one hurdle, but managing it with a chronic disease can be especially challenging. Based on what is known about COVID-19, adults living with an underlying medical condition are at heightened risk for severe illness, especially people …

January 20, 2021

4 Predictions for Diabetes Management and Technology in 2021

JANUARY 2021 Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 4 Predictions for Diabetes Management and Technology in 2021 The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the …

January 1, 2021

Glucose Control in Hospital Tied to COVID-19 Outcomes

JANUARY 2021 Quinn Phillips Glucose Control in Hospital Tied to COVID-19 Outcomes For months now, it’s been clear that diabetes is a major risk factor for worse outcomes in people who develop COVID-19. Study after study has shown that people with diabetes are more likely to be hospitalized with the viral illness, and to experience worse outcomes — including a higher risk of death …

December 28, 2020

Hyperglycemia and Hypoglycemia Associated with Poor Outcomes in COVID-19 Patients

DECEMBER 2020 LabMedica International staff writers Hyperglycemia and Hypoglycemia Associated with Poor Outcomes in COVID-19 Patients Diabetes and hyperglycemia have emerged as important risk factors for hospitalization, disease severity, acute kidney injury, acute respiratory distress syndrome, intensive care unit (ICU) admissions, and death in patients with coronavirus disease 2019 (COVID-19). Hypoglycemia, also called low blood glucose or low blood sugar, …

December 15, 2020

Glytec Publishes First COVID-19 Research to Study the ‘Opportunity Window’ for Treating Hospitalized Patients with Diabetes or Hyperglycemia

Glytec Publishes First COVID-19 Research to Study the ‘Opportunity Window’ for Treating Hospitalized Patients with Diabetes or Hyperglycemia New Research Published in Diabetes Care Journal Reveals 7x Mortality Risk for Non-ICU Patients with Severe Hyperglycemia After 2-3 Days, Indicating Need to Start Treatment on Admission WALTHAM, MASS. (December 15, 2020) – Glytec, the only provider of insulin management software across the …

December 1, 2020

Glytec Leads ADCES Webinar on Inpatient Glycemic Management During COVID-19

Glytec Leads ADCES Webinar on Inpatient Glycemic Management During COVID-19 Live Session and Q&A on December 10  Features Case Studies from Diabetes Care and Education Specialists WALTHAM, MASS. (December 1, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced it is partnering with the Association of Diabetes Care & Education Specialists (ADCES) to …

November 24, 2020

Diabetes Nurses: On the Frontlines of a Long-Term Pandemic

NOVEMBER 2020 Koren Thomas Diabetes Nurses: On the Frontlines of a Long-Term Pandemic Diabetes nurses work on the frontlines in the fight against an ongoing epidemic/pandemic that will continue to afflict over 13% of the US population long after COVID-19 recedes into the background. The diabetes pandemic has been mounting rapidly in the early 21st century. In 2003, 194 million adults worldwide between …